Production (Stage)
BioSig Technologies, Inc.
BSGM
$5.23
-$0.63-10.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -155.87% | 42.58% | 51.11% | -15.08% | 43.76% |
| Total Depreciation and Amortization | -12.68% | -52.98% | 18.90% | -18.06% | -8.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 146.09% | -295.35% | -56.42% | 347.66% | -36.10% |
| Change in Net Operating Assets | -111.79% | 343.46% | 35.63% | -656.49% | -29.86% |
| Cash from Operations | -135.23% | 68.17% | -0.54% | -12.71% | 55.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 469,900.00% | -- | -100.00% | 204.71% | -62.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 469,900.00% | -- | -100.00% | 105.78% | -43.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 857.93% | 68.23% | -188.21% | 646.90% | 213.57% |